NCT02495181
Randomized, Double-masked, Sham-controlled Phase 4 Study, Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Monotherapy Compared to Aflibercept With Adjunctive Photodynamic Therapy in Patients With Polypoidal Choroidal Vasculopathy
Phase: Phase 4
Role: Collaborator
Start: Nov 23, 2015
Completion: Dec 17, 2019